Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Hagens Berman Sobol Shapiro
Hagens Berman Sobol Shapiro: McKesson Settles RICO Lawsuit for $350 Million
December 7th, 2008
Attorneys representing consumers and third-party payers announced a proposed landmark $350 million settlement with healthcare services giant McKesson (NYSE:MCK) to settle allegations the company fraudulently inflated the price of more than 400 prescription drugs by manipulating drug-pricing benchmarks. The lawsuit, filed under the Racketeer Influenced and Corrupt Organizations Act (RICO), claimed McKesson conspired with drug publishing company First DataBank (FDB) to fraudulently inflate the widely used Average Wholesale Price (AWP) figures, which insurance companies, retailers and others use to calculate the purchase price, payments and co-payments of the most common...
Source: Pharma Investments, Ventures & Law Weekly (2008-12-07)
|
